Remodeling in acute coronary syndromes: expectations and frustrations for risk assessment and therapy.
Matrix metalloproteinases are involved in the development of acute coronary syndromes, but they are not reliable clinical markers of the occurrence or the outcome of this syndrome. Many limitations in their assessment account for such failure. Functional genetic polymorphisms, as alternatives to plasma levels, might be an interesting alternative.
Nicola
N
Fiotti
Nicola
N
Altamura
Carlo
C
Giansante
D054058:Acute Coronary Syndrome / Q000453:epidemiology / Q000503:physiopathology* / Q000628:therapy*; D006801:Humans; D018570:Risk Assessment; D020257:Ventricular Remodeling / Q000502:physiology*